Ausdal Financial Partners’s Novo Nordisk NVO Stock Holding History

Ausdal Financial Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Buy	6,315 +245	+4%	+$10.5K	0.01%	827
2026 Q1	$223K	Buy	+6,070	New	+$288K	0.01%	893
2025 Q3	–	Sell	-9,100	Closed	-$628K	–	949
2025 Q2	$628K	Buy	+9,100	New	+$619K	0.04%	368
2024 Q4	–	Sell	-3,841	Closed	-$457K	–	584
2024 Q3	$457K	Buy	3,841 +200	+5%	+$26.7K	0.05%	331
2024 Q2	$520K	Buy	3,641 +230	+7%	+$30.5K	0.06%	284
2024 Q1	$438K	Buy	3,411 +292	+9%	+$34.8K	0.05%	294
2023 Q4	$323K	Sell	3,119 -240	-7%	-$23.7K	0.04%	335
2023 Q3	$305K	Buy	+3,359	New	+$296K	0.04%	334
2016 Q1	–	Sell	-8	Closed	–	–	762
2015 Q4	$0	Buy	+8	New	+$221	﹤0.01%	1324

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ausdal Financial Partners's NVO Position: Q2 2026 in Review

Ausdal Financial Partners increased its Novo Nordisk (NVO) stake by 4% in Q2 2026, buying an estimated $10.5K and bringing the position to 6,315 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #827.

Ausdal Financial Partners first reported a position in NVO in Q4 2015 and has held it in 9 quarters since. The position peaked at $628K in Q2 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Ausdal Financial Partners held 6,315 shares of Novo Nordisk worth $303K as of Q2 2026.
Ausdal Financial Partners bought 245 Novo Nordisk shares in Q2 2026, an estimated $10.5K.
Novo Nordisk made up 0.01% of Ausdal Financial Partners's portfolio in Q2 2026, its #827 holding.
Ausdal Financial Partners first reported a position in Novo Nordisk in Q4 2015 and has held it in 9 quarters since.
Ausdal Financial Partners's Novo Nordisk position peaked at $628K in Q2 2025.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.